ALK1 signalling analysis identifies angiogenesis related genes and reveals disparity between TGF-β and constitutively active receptor induced gene expression

BMC Cardiovascular Disorders

Volumn 6, Issue , 2006, Pages

  Lux, Andreas ^a,b   Salway, Fiona ^c   Dressman, Holly K ^d   Kröner Lux, Gabriele ^e   Hafner, Mathias ^b   Day, Philip J R ^c   Marchuk, Douglas A ^d   Garland, John ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b MANNHEIM UNIVERSITY OF APPLIED SCIENCES   (Germany)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e Progen Biotechnik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; INTERLEUKIN 8; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RENDU OSLER WEBER DISEASE; SIGNAL TRANSDUCTION; UMBILICAL VEIN; UNINDEXED SEQUENCE; UPREGULATION;

ACTIVIN RECEPTORS, TYPE II; CELL LINE; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33746998477     PISSN: 14712261     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-6-13     Document Type: Article

References (95)

1. Massague J, Blain SW, Lo RS. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000, 103:295-309.
2. ten Dijke P, Hill CS: New insights into TGF-beta-Smad signalling. Trends Biochem Sci 2004, 29:265-273.
3. Blobe GC, Schiemann WP, Lodish HF: Role of transforming growth factor beta in human disease. N Engl J Med 2000, 342:1350-1358.
4. Shi Y, Massague J: Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113:685-700.
5. Pepper MS: Transforming growth factor-beta. vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rey 1997, 8:21-43.
6. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P: Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. Embo J 2002, 21:1743-1753.
7. Pepper MS, Vassalli JD, Orci L, Montesano R: Biphasic effect of transforming growth factor-beta I on in vitro angiogenesis. Exp Cell Res 1993, 204:356-363.
8. Gajdusek CM, Luo Z, Mayberg MR: Basic fibroblast growth factor and transforming growth factor beta-I: synergistic mediators of angiogenesis in vitro. J Cell Physiol 1993, 157:133-144.
9. van den Driesche S, Mummery CL, Westermann CJ: Hereditary hemorrhagic telangiectasia: an update on transforming growth factor beta signaling in vasculogenesis and angiogenesis. Cardiovasc Res 2003, 58:20-31.
10. Marchuk DA, Lux A: Hereditary Hemorrhagic Telangiectasia. In The Metabolic & Molecular Bases of Inherited Disease Volume IV. 8th edition. Edited by: Scriver CRBALVDSWS., McGraw-Hill Medical Publishing Division; 2001:5419-55431.
11. Marchuk DA, Srinivasan S, Squire TL, Zawistowski JS: Vascular morphogenesis: tales of two syndromes. Hum Mol Genet 2003, 12 Spec No 1:R97-112.
12. Braverman IM, Keh A, Jacobson BS: Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia. J Invest Dermatol 1990, 95.422-427.
13. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J, McCormick K, Pericak-Vance MA, Heutink P, Oostra BA, Haitjema T, Westerman CJJ, Porteous ME, Guttmacher AE, Letarte M, Marchuk DA: Endogiln, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type I. Nat Genet 1994, 8:345-351.
14. Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ, Stenzel TT, Speer M, Pericak-Vance MA, Diamond A, Guttmacher AE, Jackson CE, Attisano L, Kucherlapati R, Porteous ME, Marchuk DA: Mutations in the activin receptor-like kinase I gene in hereditary haemorrhagic telangiectasia type 2. Not Genet 1996, 13:189-195.
15. Gallione CJ, Repetto GM, Legius E, Rustgi AK, Schelley SL, Tejpar S, Mitchell G, Drouin E, Westermann CJ, Marchuk DA: A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 2004, 363:852-859.
16. Cheifetz: S, Bellon T, Cales C, Vera S, Bernabeu C, Massague J, Letarte M: Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem 1992, 267:19027-19030.
17. Letamendia A. Lastres P, Botella LM, Raab U, Langa C, Velasco B, Attisano L, Bernabeu C: Role of endoglin in cellular responses to transforming growth factor-beta. A comparative study with betaglycan. J Biol Chem 1998, 273:33011-33019.
18. Lux A, Attisano L, Marchuk DA: Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-I. J Biol Chem 1999, 274:9984-9992.
19. Macias-Silva M, Hoodless PA, Tang SJ, Buchwald M, Wrana JL: Specific activation of SmadI signaling pathways by the BMP7 type I receptor, ALK2. J Biol Chem 1998, 273:25628-25636.
20. Chen YG, Massague J: SmadI recognition and activation by the ALK1 group of transforming growth factor-beta family receptors. J Biol Chem 1999, 274:3672-3677.
21. Bourdeau A, Dumont DJ, Letarte M: A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest 1999, 104:1343-1351.
22. Arthur HM, Ure J, Smith AJ, Renforth G, Wilson DI, Torsney E, Charlton R, Parums DV, Jowett T, Marchuk DA, Burn J, Diamond AG: Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol 2000, 217:42-53.
23. Li DY, Sorensen LK, Brooke BS, Urness LD, Davis EC, Taylor DG, Boak BB, Wendel DP: Defective angiogenesis in mice lacking endoglin. Science 1999, 284:1534-1537.
24. Oh SP, Seki T, Goss KA Imamura T, Yi Y, Donahoe PK, Li L, Miyazono K, ten Dijke P, Kim S, Li E: Activin receptor-like kinase I modulates transforming growth factor-beta I signaling in the regulation of angiogenesis. Proc Natl Acad Sci U S A 2000, 97:2626-2631.
25. Srinivasan S, Hanes MA, Dickens T, Porteous ME, Oh SP, Hale LP, Marchuk DA: A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2. Hum Mol Genet 2003, 12:473-482.
26. Torsney E, Charlton R, Diamond AG, Burn J, Soames JV, Arthur HM: Mouse model for hereditary hemorrhagic telangiectasia has a generalized vascular abnormality. Circulation 2003, 107:1653-1657.
27. Lebrin F, Goumans MJ, Jonker L, Carvalho RL, Valdimarsdottir G, Thorikay M, Mummery C, Arthur HM, ten Dijke P: Endoglin promotes endothelial cell proliferation and TGF-beta/ALKI signal transduction. Embo J 2004, 23:4018-4028.
28. Blanco FJ, Santibanez JF, Guerrero-Esteo M, Langa C, Vary CP, Bernabeu C: Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-beta receptor complex. J Cell Physiol 2005, 204:574-584.
29. Goumans MJ, Valdimarsdottir G, Itoh S, Lebrin F, Larsson J, Mummery C, Karlsson S, ten Dijke P: Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell 2003, 12:817-828.
30. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, Lawley TJ: HMEC-I: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992, 99:683-690.
31. Fontijn R, Hop C, Brinkman HJ, Slater R, Westerveld A, van Mourik JA, Pannekoek H: Maintenance of vascular endothelial cell-specific properties after immortalization with an amphotrophic replication-deficient retrovirus containing human papilloma virus 16 E6/ E7 DNA. Exp Cell Res 1995, 216:199-207.
32. Hardy S, Kitamura M, Harris-Stansil T, Dai Y, Phipps ML: Construction of adenovirus vectors through Cre-Iox recombination. J Virol 1997, 71:1842-1849.
33. http://www.affymetrix.com/index.affx]]
34. http://www.data.cgt.duke.edu/Andreas.php]]
35. Ota T, Fujii M, Sugizaki T, Ishii M, Miyazawa K, Aburatani H, Miyazono K: Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-beta in human umbilical vein endothelial cells. J Cell Physiol 2002, 193:299-318.
36. Lamouille S, Mallet C, Feige JJ, Bailly S: Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis. Blood 2002, 100;4465-4501.
37. Morgan TE, Rozovsky I, Sarkar DK, Young-Chan CS, Nichols NR, Laping NJ, Finch CE: Transforming growth factor-beta I induces transforming growth factor-betaI and transforming growth factor-beta receptor messenger RNAs and reduces complement ClqB messenger RNA in rat brain microglia. Neuro-science 2000, 101:313-321.
38. Sadick H, Riedel F, Naim R, Goessler U, Hormann K, Hafner M, Lux A: Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta 1 as well as high ALK1 tissue expression. Haematologica 2005, 90:818-828.
39. Belperio JA, Keane MP, Arenberg DA. Addison CL, Ehlert JE, Burdick MD, Strieter RM: CXC chemokines in angiogenesis. J Leukoc Biol 2000, 68:1-8.
40. Bagnato A, Spinella F: Emerging role of endothelin-I in tumor angiogenesis. Trends Endocrinol Metab 2003, 14:44-50.
41. Boengler K, Pipp F, Fernandez B, Ziegelhoeffer T, Schaper W, Deindl E: Arteriogenesis is associated with an induction of the cardiac ankyrin repeat protein (carp). Cardiovasc Res 2003, 59:573-581.
42. Takahashi T, Takahashi K, St John PL, Fleming PA, Tomemori T, Watanabe T, Abrahamson DR, Drake CJ, Shirasawa T, Daniel TO: A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development. Mol Cell Biol 2003, 23:1817-1831.
43. Sakurai D, Tsuchiya N, Yamaguchi A, Okaji Y, Tsuno NH, Kobata T, Takahashi K. Tokunaga K: Crucial role of inhibitor of DNA binding/ differentiation in the vascular endothelial growth factor-induced activation and angiogenic processes of human endothelial cells. J Immunol 2004, 173:5801-5809.
44. Volpert OV, Pili R, Sikder HA, Nelius T, Zaichuk T, Morris C, Shiflett CB, Devlin MK, Conant K, Alani RM: IdI regulates angiogenesis through transcriptional repression of thrombospondin-1. Cancer Cell 2002, 2:473-483.
45. Haghnegahdar H, Du J, Wang D, Strieter RM, Burdick MD, Nanney LB, Cardwell N, Luan J, Shattuck-Brandt R, Richmond A. The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma. J Leukoc Biol 2000, 67:53-62.
46. Vargesson N, Laufer E Smad7 misexpression during embryonic angiogenesis causes vascular dilation and malformations independently of vascular smooth muscle cell function. Dev Biol 2001, 240:499-516.
47. Bussolati B, Ahmed A, Pemberton H, Landis RC, Di Carlo F, Haskard DO, Mason JC: Bifunctional role for VEGF-induced heme oxygenase-I in vivo: induction of angiogenesis and inhibition of leukocytic infiltration. Blood 2004, 103:761-766.
48. Dulak J, Loboda A, Zagorska A, Jozkowicz A: Complex role of heme oxygenase-I in angiogenesis. Antioxid Redox Signal 2004, 6:858-866.
49. Adini I, Rabinovitz I, Sun JF, Prendergast GC, Benjamin LE: RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular development. Genes Dev 2003, 17:2721-2732.
50. Bakre MM, Zhu Y, Yin H, Burton DW, Terkeltaub R, Deftos LJ, Varner JA: Parathyroid hormone-related peptide is a naturally occurring, protein Kinase A-dependent angiogenesis inhibitor. Nat Med 2002, 8:995-1003.
51. Akino K, Ohtsuru A, Kanda K, Yasuda A, Yamamoto T, Akino Y, Naito S, Kurokawa M, Iwahori N, Yamashita S: Parathyroid hormone-related peptide is a potent tumor angiogenic factor. Endocrinology 2000, 141:4313-4316.
52. Nikitakis NG, Rivera H, Lopes MA, Siavash H, Reynolds MA, Ord RA, Sauk JJ: Immunohistochemical expression of angiogenesis-related markers in oral squamous cell carcinomas with multiple metastatic lymph nodes. Am J Clin Pathol 2003, 119:574-586.
53. Shawber CJ, Kitajewski J: Notch function in the vasculature: insights from zebrafish, mouse and man. Bioessays 2004, 26:225-234.
54. Ruppel KM, Willison D, Kataoka H, Wang A, Zheng YW, Cornelissen I, Yin L, Xu SM, Coughlin SR: Essential role for Galpha13 in endothelial cells during embryonic development. Proc Natl Acad Sci U S A 2005, 102:8281-8286.
55. Shie JL, Wu G, Wu J, Liu FF, Laham RJ, Oettgen P, Li J: RTEF-1, a novel transcriptional stimulator of vascular endothelial growth factor in hypoxic endothelial cells. J Biol Chem 2004, 279:25010-25016.
56. Xue Y, Gao X, Lindsell CE, Norton CR, Chang B, Hicks C, Gendron-Maguire M, Rand EB, Weinmaster G, Gridley T: Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged I. Hum Mol Genet 1999, 8:723-730.
57. Kamath BM, Spinner NB, Emerick KM, Chudley AE, Booth C, Piccoli DA, Krantz ID: Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality. Circulation 2004, 109:1354-1358.
58. Martelli-Junior H, Cotrim P, Graner E, Sauk JJ, Coletta RD: Effect of transforming growth factor-beta1, interleukin-6, and interferon-gamma on the expression of type I collagen, heat shock protein 47, matrix metalloproteinase (MMP)-1 and MMP-2 by fibroblasts from normal gingiva and hereditary gingival fibromatosis. J Periodontol 2003, 74:296-306.
59. Kahai S, Vary CP, Gao Y, Seth A: Collagen, type V, alphal (COL5A1) is regulated by TGF-beta in osteoblasts. Matrix Biol 2004, 23:445-455.
60. Lawrence R, Hartmann DJ, Sonenshein GE: Transforming growth factor beta I stimulates type V collagen expression in bovine vascular smooth muscle cells. J Biol Chem 1994, 269:9603-9609.
61. Wenstrup RJ, Florer JB, Willing MC, Giunta C, Steinmann B, Young F, Susic M, Cole WG: COL5AI haploinsufficiency is a common molecular mechanism underlying the classical form of EDS. Am J Hum Genet 2000, 66:1766-1776.
62. Wenstrup RJ, Florer JB, Brunskill EW, Bell SM, Chervoneva I, Birk DE: Type V collagen controls the initiation of collagen fibril assembly. J Biol Chem 2004, 279:53331-53337.
63. Trembath RC: Mutations in the TGF-beta type I receptor, ALK1, in combined primary pulmonary hypertension and hereditary haemorrhagic telangiectasia, implies pathway specificity. J Heart Lung Transplant 2001, 20:175.
64. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O, Voelkel NF, Rabinovitch M: Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004, 43:13S-24S.
65. Chen YH, Yet SF, Perrella MA: Role of heme oxygenase-I in the regulation of blood pressure and cardiac function. Exp Biol Med (Maywood) 2003, 228:447-453.
66. King KE, lyemere VP, Weissberg PL, Shanahan CM: Kruppel-like factor 4 (KLF4/GKLF) is a target of bone morphogenetic proteins and transforming growth factor beta I in the regulation of vascular smooth muscle cell phenotype. J Biol Chem 2003, 278:11661-11669.
67. Wu X, Ma J, Han JD, Wang N, Chen YG: Distinct regulation of gene expression in human endothelial cells by TGF-beta and its receptors. Microvasc Res 2006, 71:12-19.
68. Brown MA, Zhao Q, Baker KA, Naik C, Chen C, Pukac L, Singh M, Tsareva T, Parice Y, Mahoney A, Roschke V, Sanyal I, Choe S: Crystal Structure of BMP-9 and Functional Interactions with Pro-region and Receptors. J Biol Chem 2005, 280:25111-25118.
69. Konig HG, Kogel D, Rami A, Prehn JH: TGF-{beta}I activates two distinct type I receptors in neurons: implications for neuronal NF-{kappa}B signaling. J Cell Biol 2005, 168:1077-1086.
70. Xie L, Law BK, Aakre ME, Edgerton M, Shyr Y, Bhowmick NA, Moses HL: Transforming growth factor beta-regulated gene expression in a mouse mammary gland epithelial cell line. Breast Cancer Res 2003, 5:R187-98.
71. Shi Y, Reitmaier B, Regenbogen J, Slowey RM, Opalenik SR, Wolf E, Goppelt A, Davidson JM: CARP, a cardiac ankyrin repeat protein, is up-regulated during wound healing and induces angiogenesis in experimental granulation tissue. Am J Pathol 2005, 166:303-312.
72. Kumar NM, Rabadi NH, Sigurdson LS, Schunemann HJ, Lwebuga-Mukasa JS: Induction of interleukin-1 and interleukin-8 mRNAs and proteins by TGF beta I in rat lung alveolar epithelial cells. J Cell Physiol 1996, 169:186-199.
73. Fong CY, Pang L, Holland E, Knox AJ: TGF-beta1 stimulates IL-8 release, COX-2 expression, and PGE(2) release in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2000, 279:L201-7.
74. Chen CC, Manning AM: TGF-beta 1, IL-10 and IL-4 differentially modulate the cytokine-induced expression of IL-6 and IL-8 in human endothelial cells. Cytokine 1996, 8:58-65.
75. Rodriguez-Pascual F, Redondo-Horcajo M, Lamas S: Functional cooperation between Smad proteins and activator protein-1 regulates transforming growth factor-beta-mediated induction of endothelin-1 expression. Circ Res 2003, 92:1288-1295.
76. Ferguson CM, Schwarz EM, Puzas JE, Zuscik MJ, Drissi H, O'Keefe RJ: Transforming growth factor-beta1 induced alteration of skeletal morphogenesis in vivo. J Orthop Res 2004, 22:687-696.
77. Ning W, Song R, Li C, Park E, Mohsenin A, Choi AM, Choi Me: TGF-beta1 stimulates HO-1 via the p38 mitogen-activated protein kinase in A549 pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 2002, 283:L1094-102.
78. Zavadil J, Cermak L, Soto-Nieves N, Bottinger EP: Integration of TGF-beta/Smad and JaggedI/Notch signalling in epithelial-to-mesenchymal transition. Embo J 2004, 23:1155-1165.
79. Lindemann RK, Nordheim A, Dittmer J: Interfering with TGF beta-induced Smad3 nuclear accumulation differentially affects TGFbeta-dependent gene expression. Mol Cancer 2003, 2:20.
80. Kakonen SM, Selander KS, Chirgwin JM, Yin JJ, Burns S, Rankin WA, Grubbs BG, Dallas M, Cui Y, Guise TA. Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways. J Biol Chem 2002, 277:24571-24578.
81. Schiffer M, Schiffer LE, Gupta A, Shaw AS, Roberts IS, Mundel P, Bottinger EP: Inhibitory smads and tgf-Beta signaling in glomerular cells. J Am Soc Nephrol 2002, 13:2657-2666.
82. Wheeler AP, Ridley AJ: Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility. Exp Cell Res 2004, 301.43-49.
83. Rius C, Smith JD, Almendro N, Langa C, Botella LM, Marchuk DA, Vary CP, Bernabeu C: Cloning of the promoter region of human endoglin, the target gene for hereditary hemorrhagic telangiectasia type I. Blood 1998, 92:4677-4690.
84. Zheng M. McKeown-Longo PJ: Regulation of HEF1 expression and phosphorylation by TGF-beta I and cell adhesion. J Biol Chem 2002, 277:39599-39608.
85. Kumarapeli AR, Wang X: Genetic modification of the heart: chaperones and the cytoskeleton. J Mol Cell Cardiol 2004, 37:1097-1109.
86. Welge-Lussen U, Bioemendal H, Lutjen-Drecoll E: Transforming growth factor-beta: a growth factor inducing alpha B-crystallin expression in ciliary muscle cells. Graefes Arch Clin Exp Ophthalmol 2000, 238:993-997.
87. Zhao X, Ramsey KE, Stephan DA, Russell P: Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth factor-beta. Invest Ophthalmol Vis Sci 2004, 45:4023-4034.
88. Battelino T, Miralles F, Krzisnik C, Scharfmann R, Czernichow P: TGF-beta activates genes identified by differential mRNA display in pancreatic rudiments. Pflugers Arch 2000, 439:R26-8.
89. Oda T, Ohka S, Nomoto A: Ligand stimulation of CD155alpha inhibits cell adhesion and enhances cell migration in fibroblasts. Biochem Biophys Res Commun 2004, 319:1253-1264.
90. Feral CC, Nishiya N, Fenczik CA, Stuhlmann H, Slepak M, Ginsberg MH: CD98hc (SLC3A2) mediates integrin signaling. Proc Natl Acad Sci U S A 2005, 102:355-360.
91. Fang X, Chen T, Tran K, Parker CS: Developmental regulation of the heat shock response by nuclear transport factor karyopherin-alpha3. Development 2001, 128:3349-3358.
92. Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M, Conti L, Cataudella. T, Leavitt BR, Hayden MR, Timmusk T, Rigamonti D, Cattaneo E: Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet 2003, 35:76-83.
93. Cheong A, Bingham AJ, Li J, Kumar B, Sukumar P, Munsch C, Buckley NJ, Neylon CB, Porter KE, Beech DJ, Wood IC: Downregulated REST transcription factor is a switch enabling critical potassium channel expression and cell proliferation. Mol Cell 2005, 20:45-52.
94. Steele-Perkins G, Plachez C, Butz KG, Yang G, Bachurski CJ, Kinsman SL, Litwack ED, Richards LJ, Gronostajski RM: The transcription factor gene Nfib is essential for both lung maturation and brain development. Mol Cell Biol 2005, 25:685-698.
95. Richardson KS, Zundel W: The emerging role of the COP9 signalosome in cancer. Mol Cancer Res 2005, 3:645-653.